Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-02-15
2005-02-15
Eyler, Yvonne (Department: 1646)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S320100, C435S325000
Reexamination Certificate
active
06855507
ABSTRACT:
Under the knowledge which two kinds of intracellular signal transfer mechanism of TGF-β super family receptor exist: a pathway via Smad molecule and a pathway via novel MAP kinase such as TAB1 and TAK1, and the knowledge of interaction of Smad molecule with intranuclear receptor or CBP/p300 on the transcription control by Smad molecule, a screening method and a molecular designing method for pharmaceuticals with identified site of action and higher specificity can be accomplished.
REFERENCES:
Nakao A, et al. TGF-beta receptor-mediated signalling through Jmadz, Smad3 and Smad4. EMBO J. 1997 SEp 1;16(17):5353 62.*
Liu F et al. Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible trascriptional complexes. Genes Dev. 1997 Dec. 1:11(23):3157-67.*
Pouponnot C, Jayaraman L, Massague J. Physical and functional interaction of SMADs and p300/CBP. J Biol Chem. 1998 Sep. 4;273(36):22865-8.*
Janknecht R, Wells NJ, Hunter T. TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/P300. Genes Dev. Jul. 15, 1998;12(14):2114-9.*
Erica A. Golemis, Ilya Serebriiskii, Jeno Gyuris, & Roger Brent; Current Protocls in Molecular Biology (1996): “Analysis of Protein Interactions”; pp. 20.0.1-20.1.3; John Wiley & Sons, Inc.
Clontech Laboratories, Inc., Palo Alto, CA; “Mammalian Matchmaker Two-Hybride Assay Kit”; User Manual, (PT3002-1); Catalog #K1602-1; pp. 7-13.
Jeno Gyuris, Erica Golemis, Helen Chertkov & Rober Brent; “Cdi1, a Human G1 and S Phase Protein Phosphatase that Associates with Cdk2”; Cell, Nov. 19, 1993, vol. 75, pp. 791-803.
Roger Brent and Mark Ptashne; “A Eukaryotic Transcriptional Activator Bearing the DNA Specificty of a Prokaryotic Repressor”; Cell; Dec. 1985 (Part 2); vol., 43, pp. 729-736.
Erica A. Golemis & Robert Brent; “Fused Protein Domains Inhibit DNA Binding by LexA”; Molecular and Cellular Biology; Jul. 1992, pp. 3006-3014; vol. 12, No. 7.
Edward Giniger, Susan M. Varnum & Mark Ptashne; “Specific DNA Binding of GAL4, A Positive Regulatory Protein of Yeast”; Cell, vol. 40; Apr. 1985, pp. 767-774.
Alan G. Hinnebusch; “Evidence for Translational Regulation of the Activator of General Amino Acid Control in Yeast”; Proc. Natl, Acad. Sci., USA; vol. 81; Oct. 1984, pp. 6442-6446.
Steven J. Triezenberg, Robert C. Kingsbury, & Steven L. McKnight; “Functional Dissection of VP16, the Transactivator of Herpes Simplex Virus Immediate Early Gene Expression”; Genes & Development, Cold Spring Harbor Laboratory, 1988, vol. 2, pp. 718-729.
Garry P. Nolan, Sankar Ghosh, Hsiou-Chi Liou, Paul Tempst, & David Baltimore; “DNA Binding and IKB Inhibition of the Cloned p65 Subunit of NF-KB, a rel-Related Polypeptide”; Cell. vol. 64, Mar. 8, 1991, pp. 961-969.
Richard A. Sturm, Gokul Das, & Winship Herr; “The Ubiquitous Octamer-Binding Protein Oct-1 Contains a POU Domain with a Homeo Box Subdomain”; Genes & Development, Cold Spring Harbor Laboratory, 1988, vol. 2, pp. 1582-1599.
Rosemary Watt, Lawrence W. Stanton, Kenneth B. Marcu, Robert C. Gallo, Carlo M. Croce, & Giovanni Rovera; “Nucleotide Sequence of Cloned cDNA of Human c-myc Oncogene”; Nature, vol. 303, Jun. 23, 1983, pp. 725-728.
Peter Angel, Kazue Hattori, Tod Smeal, & Michael Karin; “The Jun Proto-Oncogene is Positively Autoregulated by Its Product, Jun/AP-1”; Cell, vol. 55, Dec. 2, 1988, pp. 875-885.
Woodring E. Wright, David A. Sassoon, & Victor K. Lin; “Myogenin, A Factor Regulating Myogenesis, Has a Domain Homologous to MyoD”; Cell, vol. 56, Feb. 24, 1989, pp. 607-617.
Istvan Mucsi and Howard J. Goldberg; “Dominant-Negative SMAD-3 Interferes with Transcriptional Activation by Mulitple Agonists”; Biochemical and Biophyscial Research Communications, vol. 232; Article No. RC976321; 1997, pp. 517-521.
Chumakov, P.M., Genetika, 1988, 24:602-612.
Massagué et al.; “TGF-β Signalling through the Smad Pathway”; Trends in Cell Biology, vol. 7, May 1997, pp. 187-192.
Yanagisawa, et al., “Convergence of Transforming Growth Factor-β and Vitamin D Signaling Pathways on SMAD Transcriptional Coactivators”;Science, vol. 283, Feb. 26, 1999, pp. 1317-1321.
Kato Shigeaki
Yanagisawa Jun
Chugai Seiyaku Kabushiki Kaisha
Eyler Yvonne
Morgan & Lewis & Bockius, LLP
Murphy Joseph F.
LandOfFree
Method of screening for pharmaceuticals by detecting cross... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of screening for pharmaceuticals by detecting cross..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of screening for pharmaceuticals by detecting cross... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3463604